If you are:
Possibly Safe: INSUFFICIENT HUMAN DATA AVAILABLE
Only When Necessary: HYPOGLYCEMIA RISK IN NEONATE,SHOULD DISCONTINUE 1 MONTH PRIOR TO DELIVERY DATE
Precaution: NO KNOWN INFANT ADVERSE OUTCOMES; MFR ADVISES CAUTION
Precaution: LIMITED DATA SUGGEST MINIMAL AMOUNT EXCRETED W/NO KNOWN INFANT ADV EFFECT
An adult over 60:
management or monitoring precaution: Higher risk of hypoglycemia. Use conservative maintenance dose.
management or monitoring precaution: Renal-Increased risk for drug induced metabolic acidosis with increasing age and declining renal function. Metformin is contraindicated in patients with an eGFR below 30 mL/min. Cardiovascular-Heart failure patients may have a higher risk for metabolic acidosis.
Giving Metaglip tablet to a child under 12:
management or monitoring precaution: Safety and efficacy in children not established.
management or monitoring precaution: Safety and efficacy in pediatrics age < 10 years not established.